Inactief instrument

Andere talen Tikun Olam-Cannbit Pharmaceuticals Ltd TEL AVIV STOCK EXCHANGE

Aandelen

Tikun Olam-Cannbit Pharmaceuticals Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	31/03
Tikun Olam-Cannbit Pharmaceuticals Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	22-08-23
Tikun Olam-Cannbit Pharmaceuticals Ltd Auditor Raises 'Going Concern' Doubt	28-03-23
Tikun Olam-Cannbit Pharmaceuticals Ltd and Ambrosia-Supherb Signs an Exclusive Partnership Agreement	19-08-21
Tikun Olam - Cannbit Pharmaceuticals Ltd Signs an Agreement with Maccabi Healthcare Services	08-07-21
Tikun Olam-Cannbit and Gynica Announce Start of A Joint Clinical Study	24-06-21
Tikun Olam Cannbit Pharmaceuticals : Canonic of Evogene Group and Tikun Olam (Israel)-Cannbit, sign production and distribution agreements for Canonic products in Israel - Evogene	25-03-21
Apex Capital Markets Ltd. acquired 23.5% stake in A.L. Capital Holdings Ltd (TASE:CPHO-M) from Apex Issuances, Investment arm for ILS 0.5 million.	28-06-17
Tamir Fishman Venture Capital II : Eucalyptus Growth Capital fund to raise $300M for late-stage Israeli companies, 12.05.15	13-05-15
Tamir Fishman Venture Capital II : Capital soars after court ruling against Teva, 28.04.15	13-05-15
Tamir Fishman Venture Capital II : Dadi Perlmutter, Rami Hadar & Tamir-Fishman Form a Partnership and Plan to Raise 300M$, 12.05.15	12-05-15

Geen resultaten voor deze zoekopdracht